The skin IHC results also confirmed that PCNA and Ki67 levels decreased in both LYS-Low and LYS-High groups (Figure 5B), suggesting that LYS treatment could reduce keratinocyte proliferation in mice with psoriasis. Here, MKI67 is linked to psoriasis.